Compare Novartis AG (NVS) vs Stanley Black & Decker, Inc. (SWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Stanley Black & Decker, Inc. — how do they compare? Novartis AG trades at $143.11 (market cap $268.57B), while Stanley Black & Decker, Inc. trades at $89.66 (market cap $13.47B). The key difference: Novartis AG is far larger — about 19.9× Stanley Black & Decker, Inc.'s market cap, and Stanley Black & Decker, Inc. pays the higher dividend (3.77%). Which is the better fit depends on your goals — on Pluang, investors hold Novartis AG for 82 Days and Stanley Black & Decker, Inc. for 62 Days on average.
| NVS | SWK | |
|---|---|---|
Market Cap | $268.57B | $13.47B |
Volume | 1,532,573 | 2,859,744 |
Sector | Health | Industrials |
52-Week High | $168.62 | $104.00 |
52-Week Low | $121.80 | $62.12 |
Typical Hold Time | 82 Days | 62 Days |
Enterprise Value | $309.89B | $17.63B |
Dividend Yield | 3.31% | 3.77% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novartis (NVS) trades at $143.28, up 1.77% on the day, with a neutral technical signal and mixed earnings history. The company reported strong 2025 revenue of $56.67B and a net income margin of 22.5%, supported by a recent $7.8B licensing deal with China's Abogen. However, recent clinical trial setbacks and an ongoing law firm investigation introduce uncertainty.
The outlook is balanced; solid profitability and a consensus price target of $146.00 suggest modest upside, but risks from pipeline failures and heightened M&A scrutiny warrant caution. Investor sentiment is mixed, with analysts predominantly holding a neutral stance amid evolving business developments.
Stanley Black & Decker (SWK) trades at $88.31, down 1.87% on the day, with a bearish technical signal from moving averages and oscillators. The company has beaten earnings estimates for the last three quarters, with Q3 2026 results expected November 4, 2026. Fundamentals show modest revenue of $15.13B in 2025 and a net income margin of 4.07%, while valuation ratios like a P/E of 21.8 and P/S of 0.89 suggest reasonable pricing. Recent news highlights product launches like the dustbuster® mini™ and management's focus on margin gains.
The outlook is mixed: analyst consensus is a 'Hold' with a $93 price target, implying ~5% upside, but technical weakness and competitive pressures pose risks. Investment appeal lies in its dividend king status and cost-saving initiatives, though investors face headwinds from higher expenses and market volatility. Earnings growth remains the key catalyst for further upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Stanley Black & Decker, Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →
